File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Comparative Effectiveness and Safety Between Apixaban, Dabigatran, Edoxaban, and Rivaroxaban Among Patients With Atrial Fibrillation

TitleComparative Effectiveness and Safety Between Apixaban, Dabigatran, Edoxaban, and Rivaroxaban Among Patients With Atrial Fibrillation
Authors
Issue Date2022
Citation
Annals of Internal Medicine, 2022, v. 175, p. 1515-1524 How to Cite?
Persistent Identifierhttp://hdl.handle.net/10722/323216
ISI Accession Number ID

 

DC FieldValueLanguage
dc.contributor.authorLau, CY-
dc.contributor.authorTorre, CO-
dc.contributor.authorMan, KCK-
dc.contributor.authorStewart, HM-
dc.contributor.authorSeager, S-
dc.contributor.authorVan Zandt, M-
dc.contributor.authorReich, C-
dc.contributor.authorLi, J-
dc.contributor.authorBrewster, J-
dc.contributor.authorLip, GYH-
dc.contributor.authorHingorani, AD-
dc.contributor.authorWei, L-
dc.contributor.authorWong, ICK-
dc.date.accessioned2022-12-02T14:05:46Z-
dc.date.available2022-12-02T14:05:46Z-
dc.date.issued2022-
dc.identifier.citationAnnals of Internal Medicine, 2022, v. 175, p. 1515-1524-
dc.identifier.urihttp://hdl.handle.net/10722/323216-
dc.languageeng-
dc.relation.ispartofAnnals of Internal Medicine-
dc.titleComparative Effectiveness and Safety Between Apixaban, Dabigatran, Edoxaban, and Rivaroxaban Among Patients With Atrial Fibrillation-
dc.typeArticle-
dc.identifier.emailWong, ICK: wongick@hku.hk-
dc.identifier.authorityWong, ICK=rp01480-
dc.identifier.doi10.7326/M22-0511-
dc.identifier.hkuros342662-
dc.identifier.volume175-
dc.identifier.spage1515-
dc.identifier.epage1524-
dc.identifier.isiWOS:000906286000022-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats